NAKAZAWA YUICHI
School of Medicine Department for the Promotion of Regional Medicine
Associate Professor
Researcher Information
Research activity information
Paper
- Optimal Initial Dose of Orally Administered Once-daily Extended-release Tacrolimus Following Intravenous Tacrolimus Therapy After Liver Transplantation
Mita, A; Ikegami, T; Masuda, Y; Katsuyama, Y; Ohno, Y; Urata, K; Nakazawa, Y; Kobayashi, A; Miyagawa, S
TRANSPLANTATION PROCEEDINGS, 46(3), 794-796, Apr. 2014
- Clinicopathological analysis of liver allograft biopsies with late centrilobular necrosis: a comparative study in 54 patients
Nakazawa Y, Walker NI, Kerlin 他４名
TRANSPLANTATION, 69(8), 1599-1608, 2000 - Fibrous obliterative lesions of veins contribute to progressive fibrosis in chronic liver allograft rejection
Nakazawa Y, Jonsson JR, Walker NI他５名
Hepatology, 32(6), 1240-1247, 2000 - Update of the International Banff Schema for Liver Allograft Rejection:working recommendations for the histopathologic staging and reporting of chronic rejection. An International Panel
Demetris A, Adams D, Nakazawa Y他３０名
Hepatology, 31(3), 792-892, 2000 - Relationship between in vivo FK506 clearance and in vitro 13-demethylation activity in living-related liver transplantation
Nakazawa Y, Chisuwa H, Ikegami T他５名
TRANSPLANTATION, 66(8), 1089-1093, 1998 - Efficacy of quantitative analysis of Epstein-Barr virus-infected peripheral blood lymphocytes by in situ hybridization of EBER1 after living-related livertransplantation: a case report
Nakazawa Y, Chisuwa H, Ikegami T他５名
TRANSPLANTATION, 63(9), 1363-1366, 1997
